Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This
ASBMR report provides guidance on BP therapy duration with a risk‐benefit perspective …

Aims The aim of this systematic review and meta‐analysis was to synthesise the evidence
relating to medication non‐adherence and its association with health outcomes in people …

Most people presenting with incident osteoporotic fractures are neither assessed nor treated
for osteoporosis to reduce their risk of further fractures, despite the availability of effective …

The aim of this review was to identify factors that influence patients' adherence to anti-
osteoporotic therapy. Factors identified that were associated with poorer medication …

Скрининг для выявления групп с высокой вероятностью переломов рекомендован с
использованием алгоритма FRAX среди всех женщин в постменопаузе и мужчин …

ABSTRACT In the United States, osteoporosis affects over 10 million adults, has high
societal costs (22billionin2008),andiscurrentlybeingunderdiagnosedandun …

The final analysis of this 2-year, randomized, crossover study showed that postmenopausal
women with osteoporosis were more adherent, compliant, and persistent with subcutaneous …

Osteoporosis is a systemic skeletal disorder characterized by bone loss, which leads to
impaired bone strength and an increased risk of fractures. Two million fractures are …

Osteoporosis increases the risk of fractures, which are associated with increased mortality
and lower quality of life. Patients with prevalent fracture are at high risk to of sustaining …

BACKGROUND CONTEXT In the context of the population growing and aging worldwide,
the epidemiology, and burden of vertebral fracture have not been comprehensively …